Sickle Cell Disease Treatment Demonstration Program

Research Category

Funding Type

Internal Deadline

Wednesday, March 24, 2021


UA may submit 1 application.

The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2021 for the Sickle Cell Disease Treatment Demonstration Program (TDP). The purpose of the TDP is to increase access to quality, coordinated, comprehensive care for individuals with sickle cell disease by: 1) increasing the number of clinicians or health professionals knowledgeable about the care of SCD, 2) improving the quality of care provided to individuals with sickle cell disease, and 3) improving care coordination with other providers.

Program URL


External Deadline


Solicitation Type